Content Author

Beatrisse FenderMSci

Growth & Partnerships Lead · Personalized Peptides

Growth & Partnerships Lead at Longr, working across healthcare innovation, personalized medicine and commercial strategy. MSci in Psychology & Neuroscience from the University of Bristol. Writes educational content covering personalized medicine, peptide science, genetics, epigenetics, and emerging models of preventative and integrative healthcare. Published articles reviewed for clinical accuracy by Lynn Marie Morski, MD, JD.

Education

Degrees.

MSci in Psychology & Neuroscience — University of Bristol

Experience

Roles & appointments.

Growth & Partnerships Lead — Longr
Current
Critical Edge
Previously

Contributions

Content by Beatrisse.

Understanding Peptide Research: What the Labels Actually Mean

How DNA Testing Personalizes Your Peptide Protocol

BPC-157: What the Research Actually Shows (2026)

The GLP-1 Landscape: Semaglutide vs Tirzepatide vs Retatrutide

Cycling Peptides: A Protocol Framework for Any Stack

NAD+ Decline and Aging: The Science Behind NAD-300

FDA PCAC Review February 2027: What It Means for Peptide Access

GHK-Cu and Skin Glow: The Topical-to-Injectable Spectrum

Epigenetic Testing: Measuring How Fast You're Actually Aging

Peptide Safety: How to Evaluate Research Chemical Quality

The Cognitive Peptide Stack: SEMAX, Selank, and Dihexa Compared

Building a Recovery Protocol: From Injury to Full Function

Expertise

Areas of focus.

Personalized MedicinePeptide TherapeuticsPeptideGeneticsEpigeneticsPsychedelic MedicineIntegrative HealthcarePrecision MedicineNeuroscienceNeuroscience

Affiliations

Memberships & institutions.

Personalized Peptides Research Desk

University of Bristol, School of Psychological Science

External profiles

Verify elsewhere.

linkedin.com

Personalized Peptides follows strict sourcing guidelines — peer-reviewed research, primary sources, and named clinical review before publication. See a mistake? Tell us.

Editorial standards